Literature DB >> 17520352

National evaluation of NHS genetics service investments: emerging issues from the cancer genetics pilots.

Graham P Martin1, Rachael Finn, Graeme Currie.   

Abstract

In seeking to fulfil the ambition of the 2003 genetics white paper, Our Inheritance, Our Future, to 'mainstream' genetic knowledge and practices, the Department of Health provided start-up funding for pilot services in various clinical areas. These included seven cancer genetics projects, co-funded with Macmillan Cancer Support. To help to understand the challenges encountered by such an attempt at reconfiguring the organization and delivery of services in this field, a programme-level evaluation of the genetics projects was commissioned to consider the organizational issues faced. Using a qualitative approach, this research has involved comparative case-study work in 11 of the pilot sites, including four of the seven cancer genetics pilots. In this paper, the researchers present early findings from their work, focusing in particular on the cancer genetics pilots. They consider some of the factors that have influenced how the pilots have sought to address pre-existing sector, organizational and professional boundaries to these new ways of working. The article examines the relationship between these factors and the extent to which pilots have succeeded in setting up boundary-spanning services, dealing with human-resource issues and creating sustainable, 'mainstreamed' provision which attracts ongoing funding in a volatile National Health Service commissioning environment where funding priorities do not always favour preventive, risk-assessment services.

Entities:  

Mesh:

Year:  2007        PMID: 17520352     DOI: 10.1007/s10689-007-9130-3

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  4 in total

1.  Raising concerns about family history of breast cancer in primary care consultations: prospective, population based study. Women's Concerns Study Group.

Authors:  F Hyland; A L Kinmonth; T M Marteau; S Griffin; P Murrell; D Spiegelhalter; C Todd; F Walter; B Berrington; M Bobrow; J Mackay
Journal:  BMJ       Date:  2001-01-06

2.  Social capital.

Authors:  T Welsh; M Pringle
Journal:  BMJ       Date:  2001-07-28

Review 3.  Progress in partnerships.

Authors:  C Glendinning; A Coleman; C Shipman; G Malbon
Journal:  BMJ       Date:  2001-07-07

4.  No magic targets! Changing clinical practice to become more evidence based.

Authors:  Sue Dopson; Louise FitzGerald; Ewan Ferlie; John Gabbay; Louise Locock
Journal:  Health Care Manage Rev       Date:  2002
  4 in total
  6 in total

1.  Family history in primary care: understanding GPs' resistance to clinical genetics--qualitative study.

Authors:  Jonathan Mathers; Sheila Greenfield; Alison Metcalfe; Trevor Cole; Sarah Flanagan; Sue Wilson
Journal:  Br J Gen Pract       Date:  2010-05       Impact factor: 5.386

2.  Evaluation after five years of the cancer genetic counselling programme of Valencian Community (Eastern Spain).

Authors:  Dolores Cuevas-Cuerda; Dolores Salas-Trejo
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

3.  A primary care specialist genetics service: a cluster-randomised factorial trial.

Authors:  Greta Westwood; Ruth Pickering; Sue Latter; Paul Little; Karen Gerard; Anneke Lucassen; I Karen Temple
Journal:  Br J Gen Pract       Date:  2012-03       Impact factor: 5.386

4.  The medium-term sustainability of organisational innovations in the national health service.

Authors:  Graham P Martin; Graeme Currie; Rachael Finn; Ruth McDonald
Journal:  Implement Sci       Date:  2011-03-14       Impact factor: 7.327

5.  Innovation sustainability in challenging health-care contexts: embedding clinically led change in routine practice.

Authors:  Graham P Martin; Simon Weaver; Graeme Currie; Rachael Finn; Ruth McDonald
Journal:  Health Serv Manage Res       Date:  2012-11

6.  Development of cancer genetic services in the UK: A national consultation.

Authors:  Ingrid Slade; Daniel Riddell; Clare Turnbull; Helen Hanson; Nazneen Rahman
Journal:  Genome Med       Date:  2015-02-02       Impact factor: 11.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.